Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Ricart

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Current status of mesenchymal stem cell therapy and bone marrow transplantation in IBDElena Ricart
Current Drug Targets|April 2, 2016
Can we Monitor a Patient with Inflammatory Bowel Disease and Adapt Treatment without Endoscopy?Julian Panes, Elena Ricart
Current Opinion in Gastroenterology|April 15, 2025
Hematopoietic stem cell transplantation in Crohn's disease: a comprehensive reviewAkshita Gupta, Elena Ricart, Louis Cohen
Expert Review of Clinical Immunology|July 3, 2010
Stem cell treatment for Crohn's diseaseJulián Panés, Ingrid Ordás, Elena Ricart
Current Drug Targets|April 7, 2011
Lessons to learn from Crohn's disease clinical trials: implications for ulcerative colitisAránzazu Jáuregui-Amézaga, Elena Ricart, Julián Panés
Drugs of Today (Barcelona, Spain : 1998)|February 13, 2003
The therapeutic spectrum of infliximab and tumor necrosis factor immunomodulation in chronic inflammatory diseasesElena Ricart, Gerd Bouma, Amado Salvador Peña
Gastroenterologia Y Hepatologia|February 22, 2011
[Dendritic cells: a new horizon in cell therapy for inflammatory bowel disease?]Elena Ricart, Julián Panés, Daniel Benítez-Ribas
Drugs|January 30, 2010
Optimizing the use of tumour necrosis factor inhibitors in Crohn's disease: a practical approachMaria Josefina Etchevers, Ingrid Ordás, Elena Ricart
World Journal of Gastroenterology|September 24, 2008
Are we giving biologics too late? The case for early versus late useElena Ricart, Orlando García-Bosch, Ingrid Ordás, et al.
Revista Espanola De Enfermedades Digestivas|October 14, 2017
Serrated polyposis syndrome associated with long-standing inflammatory bowel diseaseJesús Castro, Miriam Cuatrecasas, Francesc Balaguer, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Digestive Diseases (Basel, Switzerland)|July 17, 2012
Current status of mesenchymal stem cell therapy and bone marrow transplantation in IBDElena Ricart
Current Drug Targets|April 2, 2016
Can we Monitor a Patient with Inflammatory Bowel Disease and Adapt Treatment without Endoscopy?Julian Panes, Elena Ricart
Current Opinion in Gastroenterology|April 15, 2025
Hematopoietic stem cell transplantation in Crohn's disease: a comprehensive reviewAkshita Gupta, Elena Ricart, Louis Cohen
Expert Review of Clinical Immunology|July 3, 2010
Stem cell treatment for Crohn's diseaseJulián Panés, Ingrid Ordás, Elena Ricart
Current Drug Targets|April 7, 2011
Lessons to learn from Crohn's disease clinical trials: implications for ulcerative colitisAránzazu Jáuregui-Amézaga, Elena Ricart, Julián Panés
Drugs of Today (Barcelona, Spain : 1998)|February 13, 2003
The therapeutic spectrum of infliximab and tumor necrosis factor immunomodulation in chronic inflammatory diseasesElena Ricart, Gerd Bouma, Amado Salvador Peña
Gastroenterologia Y Hepatologia|February 22, 2011
[Dendritic cells: a new horizon in cell therapy for inflammatory bowel disease?]Elena Ricart, Julián Panés, Daniel Benítez-Ribas
Drugs|January 30, 2010
Optimizing the use of tumour necrosis factor inhibitors in Crohn's disease: a practical approachMaria Josefina Etchevers, Ingrid Ordás, Elena Ricart
World Journal of Gastroenterology|September 24, 2008
Are we giving biologics too late? The case for early versus late useElena Ricart, Orlando García-Bosch, Ingrid Ordás, et al.
Revista Espanola De Enfermedades Digestivas|October 14, 2017
Serrated polyposis syndrome associated with long-standing inflammatory bowel diseaseJesús Castro, Miriam Cuatrecasas, Francesc Balaguer, et al.
Pageof 14